389 related articles for article (PubMed ID: 27530870)
1. Proarrhythmic mechanisms of the common anti-diarrheal medication loperamide: revelations from the opioid abuse epidemic.
Kang J; Compton DR; Vaz RJ; Rampe D
Naunyn Schmiedebergs Arch Pharmacol; 2016 Oct; 389(10):1133-7. PubMed ID: 27530870
[TBL] [Abstract][Full Text] [Related]
2. Voltage gated ion channels blockade is the underlying mechanism of BIMU8 induced cardiotoxicity.
Iqbal SM; Lemmens-Gruber R
Toxicol Lett; 2017 Aug; 277():64-68. PubMed ID: 28552773
[TBL] [Abstract][Full Text] [Related]
3. Molecular determinants of loperamide and N-desmethyl loperamide binding in the hERG cardiac K
Vaz RJ; Kang J; Luo Y; Rampe D
Bioorg Med Chem Lett; 2018 Feb; 28(3):446-451. PubMed ID: 29274816
[TBL] [Abstract][Full Text] [Related]
4. QT interval prolongation and cardiac risk assessment for novel drugs.
Picard S; Lacroix P
Curr Opin Investig Drugs; 2003 Mar; 4(3):303-8. PubMed ID: 12735231
[TBL] [Abstract][Full Text] [Related]
5. Characterization of loperamide-mediated block of hERG channels at physiological temperature and its proarrhythmia propensity.
Sheng J; Tran PN; Li Z; Dutta S; Chang K; Colatsky T; Wu WW
J Pharmacol Toxicol Methods; 2017; 88(Pt 2):109-122. PubMed ID: 28830713
[TBL] [Abstract][Full Text] [Related]
6. Comparative pharmacology of guinea pig cardiac myocyte and cloned hERG (I(Kr)) channel.
Davie C; Pierre-Valentin J; Pollard C; Standen N; Mitcheson J; Alexander P; Thong B
J Cardiovasc Electrophysiol; 2004 Nov; 15(11):1302-9. PubMed ID: 15574182
[TBL] [Abstract][Full Text] [Related]
7. Human embryonic stem cell derived cardiac myocytes detect hERG-mediated repolarization effects, but not Nav1.5 induced depolarization delay.
Qu Y; Gao B; Fang M; Vargas HM
J Pharmacol Toxicol Methods; 2013; 68(1):74-81. PubMed ID: 23518063
[TBL] [Abstract][Full Text] [Related]
8. Azithromycin Causes a Novel Proarrhythmic Syndrome.
Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
[TBL] [Abstract][Full Text] [Related]
9. Increased cardiac risk in concomitant methadone and diazepam treatment: pharmacodynamic interactions in cardiac ion channels.
Kuryshev YA; Bruening-Wright A; Brown AM; Kirsch GE
J Cardiovasc Pharmacol; 2010 Oct; 56(4):420-30. PubMed ID: 20930594
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiological mechanisms of vandetanib-induced cardiotoxicity: Comparison of action potentials in rabbit Purkinje fibers and pluripotent stem cell-derived cardiomyocytes.
Lee HA; Hyun SA; Byun B; Chae JH; Kim KS
PLoS One; 2018; 13(4):e0195577. PubMed ID: 29630634
[TBL] [Abstract][Full Text] [Related]
11. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels.
Stoetzer C; Voelker M; Doll T; Heineke J; Wegner F; Leffler A
Anesth Analg; 2017 Jan; 124(1):52-60. PubMed ID: 27861438
[TBL] [Abstract][Full Text] [Related]
12. Does terfenadine-induced ventricular tachycardia/fibrillation directly relate to its QT prolongation and Torsades de Pointes?
Lu HR; Hermans AN; Gallacher DJ
Br J Pharmacol; 2012 Jun; 166(4):1490-502. PubMed ID: 22300168
[TBL] [Abstract][Full Text] [Related]
13. Flavonoids and hERG channels: Friends or foes?
Saponara S; Fusi F; Iovinelli D; Ahmed A; Trezza A; Spiga O; Sgaragli G; Valoti M
Eur J Pharmacol; 2021 May; 899():174030. PubMed ID: 33727059
[TBL] [Abstract][Full Text] [Related]
14. Interactions of the antimalarial drug mefloquine with the human cardiac potassium channels KvLQT1/minK and HERG.
Kang J; Chen XL; Wang L; Rampe D
J Pharmacol Exp Ther; 2001 Oct; 299(1):290-6. PubMed ID: 11561091
[TBL] [Abstract][Full Text] [Related]
15. Potent Inhibition of hERG Channels by the Over-the-Counter Antidiarrheal Agent Loperamide.
Klein MG; Haigney MCP; Mehler PS; Fatima N; Flagg TP; Krantz MJ
JACC Clin Electrophysiol; 2016 Dec; 2(7):784-789. PubMed ID: 29759761
[TBL] [Abstract][Full Text] [Related]
16. An evaluation of 30 clinical drugs against the comprehensive in vitro proarrhythmia assay (CiPA) proposed ion channel panel.
Crumb WJ; Vicente J; Johannesen L; Strauss DG
J Pharmacol Toxicol Methods; 2016; 81():251-62. PubMed ID: 27060526
[TBL] [Abstract][Full Text] [Related]
17. Cellular mechanisms for trazodone-induced cardiotoxicity.
Lee S; Lee HA; Kim SJ; Kim KS
Hum Exp Toxicol; 2016 May; 35(5):501-10. PubMed ID: 26187900
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the heart's electrical properties by the anticonvulsant drug retigabine.
Rubi L; Kovar M; Zebedin-Brandl E; Koenig X; Dominguez-Rodriguez M; Todt H; Kubista H; Boehm S; Hilber K
Toxicol Appl Pharmacol; 2017 Aug; 329():309-317. PubMed ID: 28641963
[TBL] [Abstract][Full Text] [Related]
19. Predictive model for L-type channel inhibition: multichannel block in QT prolongation risk assessment.
Wiśniowska B; Mendyk A; Fijorek K; Glinka A; Polak S
J Appl Toxicol; 2012 Oct; 32(10):858-66. PubMed ID: 22761000
[TBL] [Abstract][Full Text] [Related]
20. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
